Clinical study on compound centella asiatica in treating diabetic kidney disease by regulating intestinal microflora metabolism
10.3969/j.issn.1673-9701.2025.21.014
- VernacularTitle:复方积雪草通过调节肠道菌群代谢治疗糖尿病肾病的临床研究
- Author:
Like RAO
1
;
Yina ZHOU
1
;
Xuanzhu WU
1
;
Jianfei WU
1
;
Daojie YANG
1
Author Information
1. 杭州市第九人民医院中医科,浙江 杭州 311225
- Publication Type:Journal Article
- Keywords:
Compound centella asiatica;
Diabetic kidney disease;
Metabolism of gut microbiota;
Urine protein
- From:
China Modern Doctor
2025;63(21):61-63,114
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the effect of compound centella asiatica on diabetic kidney disease(DKD)by regulating intestinal microflora metabolism.Methods Sixty DKD patients who visited Hangzhou Ninth People's Hospital from January to December 2022 were randomly divided into experimental group and control group,with 30 patients in each group.Patients in control group received basic treatment guided by lifestyle and diet,while patients in experimental group received treatment with compound centella asiatica on the basis of control group.Both groups of patients were followed up for 6 months to measure gut microbiota metabolite levels,urinary protein,and other indicators.Results After treatment,the levels of short-chain fatty acid(SCFA)in experimental group increased,while the levels of trimethylamine oxide(TMAO),indophenol sulfate(IS),microalbuminuria/creatinine(ACR),and 24-hour urinary protein quantification(24hPro)decreased;24hPro and ACR of experimental group patients were lower than those of control group.ACR in DKD patients is positively correlated with TMAO and negatively correlated with SCFA(P＜0.05).Conclusion ACR in DKD patients is positively correlated with TMAO and negatively correlated with SCFA;Compound centella asiatica can increase the levels of SCFA in DKD patients,reduce the levels of TMAO,IS,and ACR,indicating that compound centella asiatica can regulate the metabolic levels of gut microbiota in DKD patients and reduce proteinuria.
